Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The number of shares of the issuer's common stock, par value $0.01 per share (the ''Common Stock''), outstanding and beneficially owned by the reporting person disclosed in this Amendment No. 2 to Statement on Schedule 13G (this ''Amendment No. 2'') give effect to the 1-for-200 reverse split of the outstanding shares of Common Stock effected by the issuer on February 10, 2025 (the ''Reverse Stock Split''). As more fully described in Item 4 of this Amendment No. 2, such shares and percentage are based on 2,514,571 shares of Common Stock outstanding as of May 14, 2025, as disclosed in the issuer's Quarterly Report on Form 10-Q for the period ended March 31, 2025, as filed with the U.S. Securities and Exchange Commission (the ''SEC'') on May 15, 2025 (the "Form 10-Q''), and do not give full effect to the exercise of the Series A common stock purchase warrants of the issuer (the "Warrants'') directly owned by the reporting person, further exercise of which is subject to a 9.99% beneficial ownership limitation provision (the ''Blocker'').


SCHEDULE 13G




Comment for Type of Reporting Person:  The number of shares of Common Stock outstanding and beneficially owned by the reporting person disclosed in this Amendment No. 2 give effect to the Reverse Stock Split. As more fully described in Item 4 of this Amendment No. 2, such shares and percentage are based on 2,514,571 shares of Common Stock outstanding as of May 14, 2025, as disclosed in the Form 10-Q, and do not give full effect to the exercise of the Warrants indirectly owned by the reporting person, further exercise of which is subject to a Blocker.


SCHEDULE 13G




Comment for Type of Reporting Person:  The number of shares of Common Stock outstanding and beneficially owned by the reporting person disclosed in this Amendment No. 2 give effect to the Reverse Stock Split. As more fully described in Item 4 of this Amendment No. 2, such shares and percentage are based on 2,514,571 shares of Common Stock outstanding as of May 14, 2025, as disclosed in the Form 10-Q, and do not give full effect to the exercise of the Warrants indirectly owned by the reporting person, further exercise of which is subject to a Blocker.


SCHEDULE 13G




Comment for Type of Reporting Person:  The number of shares of Common Stock outstanding and beneficially owned by the reporting person disclosed in this Amendment No. 2 give effect to the Reverse Stock Split. As more fully described in Item 4 of this Amendment No. 2, such shares and percentage are based on 2,514,571 shares of Common Stock outstanding as of May 14, 2025, as disclosed in the Form 10-Q, and do not give full effect to the exercise of the Warrants indirectly owned by the reporting person, further exercise of which is subject to a Blocker.


SCHEDULE 13G



 
Ionic Ventures, LLC
 
Signature:/s/ Ionic Ventures, LLC
Name/Title:Keith Coulston, Manager of Ionic Management, LLC, Manager of Ionic Ventures, LLC
Date:08/13/2025
 
Ionic Management, LLC
 
Signature:/s/ Ionic Management, LLC
Name/Title:Keith Coulston, Manager
Date:08/13/2025
 
Brendan O'Neil
 
Signature:/s/ Brendan O'Neil
Name/Title:Brendan O'Neil
Date:08/13/2025
 
Keith Coulston
 
Signature:/s/ Keith Coulston
Name/Title:Keith Coulston
Date:08/13/2025

Comments accompanying signature:  LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated February 4, 2025 (incorporated by reference to Exhibit 1 to the Schedule 13G filed by the Reporting Persons with the SEC on February 4, 2025).